Apexigen's Series A Round

Apexigen raised a round of funding on August 07, 2013.

Apexigen is a biopharmaceutical product development company advancing a pipeline of product candidates with the potential to address life-threatening and difficult to treat diseases. The company's tec…

Articles about Apexigen's Series A Round: